Compare Novavax Inc (NVAX) vs Nuscale Power Corporation (SMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Nuscale Power Corporation — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Nuscale Power Corporation trades at $8.81 (market cap $2.76B). The key difference: Nuscale Power Corporation is far larger — about 2.1× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Nuscale Power Corporation nearer its low. Which is the better fit depends on your goals.
| NVAX | SMR | |
|---|---|---|
Market Cap | $1.30B | $2.76B |
Sector | Health | Utilities |
52-Week High | $11.19 | $53.43 |
52-Week Low | $6.22 | $7.64 |
Enterprise Value | $800.50M | $1.87B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Nuscale Power Corporation
NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →
